Introduction
NF-kB inducible genes are involved in the control of the cell cycle and of apoptosis. Some of these genes are supposed to confer resistance to apoptosis induced by various cytotoxic stimuli like FasL and TNFa (Dudley et al., 1999) or DNA damaging insults (Wang et al., 1999a) . Blockade of NF-kB activation renders several cell types being more susceptible to apoptotic triggers (Liu et al., 1996; Van Antwerp et al., 1996) and in turn, exaggerated NF-kB recruitment abundantly prevents apoptosis (reviewed in Barkett and Gilmore, 1999) , a condition that may relate to the development of certain malignant tumors (reviewed in Rayet and Gelinas, 1999) . In addition, NF-kB modulates the panel of important mediators of the cell cycle and hereby triggers the growth of various, but not all cell types (Guttridge et al., 1999; Wang et al., 1996) . However, under certain conditions NF-kB activation does not prevent but rather triggers apoptosis (Abbadie et al., 1993; Usami et al., 1998; Qin et al., 1999; Kaltschmidt et al., 2000) . This might involve particular NF-kB target genes that are of functional duality in terms of growth control and survival and that are subject of modulation by many other cellular signals.
One of these NF-kB target genes is the growth associated early response gene p22 PRG1/IEX-1 (Charles et al., 1993; Kondratyev et al., 1996; SchaÈ fer et al., 1996) . The role of p22 PRG1/IEX-1 in apoptotic signaling and cell cycle control is a controversial issue. On the one hand, p22 PRG1/IEX-1 has been shown to be involved in cellular responses initiated by the tumor suppressor p53 (SchaÈ fer et al., 1998a) , thus qualifying p22 PRG1/IEX-1 as a gene contributing to growth control and apoptosis. On the other hand, p22
PRG1/IEX-1 is a target gene for NFkB (SchaÈ fer et al., 1998b; Pietzsch et al., 1998) and could be regarded as a potential anti-apoptotic gene involved in NF-kB mediated resistance to apoptosis. In an apparent support of the latter, a non-splicing variant of p22 PRG1/IEX-1 has been reported accounting for NF-kB dependent inhibition of apoptosis (Wu et al., 1998) . Meanwhile, it has been shown that IEX-1L is merely a mutated variant of p22 PRG1/IEX-1 not existing in vivo, and its presumed anti-apoptotic action has been shown to be due to a functional interference with the wild-type variant of p22 PRG1/IEX-1 (SchaÈ fer et al., 1999) . In order to check whether p22 PRG1/IEX-1 plays a role in the NF-kB dependent regulation of cell growth and survival, we investigated the expression of p22 in HeLa cells in response to TNFa and elucidated the in¯uence of p22 PRG1/IEX-1 on cell death, induced by TNFa and other pro-apoptotic stimuli.
( Figure 1a) , as shown by RT ± PCR. This increase of the p22 PRG1/IEX-1 mRNA content persisted for 1 h, followed by a decline to initial levels after 3 ± 4 h. During the entire period, mRNA levels of b-actin did not change signi®cantly. TNFa-inducible expression of p22 PRG1/IEX-1 in HeLa cells was further demonstrated by Western blotting. As shown in Figure 1b , an intensively immunostained band corresponding to a 22 kDa protein was detectable in HeLa cells when treated with TNFa for 3 ± 4 h. Over a period of 8 ± 12 h, the protein level of p22 PRG1/IEX-1 remained high, then it decreased down to basal after 24 h.
TNFa-dependent recruitment of p22
PRG1/IEX-1 requires NF-kB activity Since TNFa-dependent gene transcription largely requires NF-kB activity, TNFa-inducible expression of p22 PRG1/IEX-1 was checked in the presence of speci®c NF-kB inhibitors. As shown by EMSA (Figure 2a) , addition of agents that block NF-kB activation ± here MG-132, gliotoxin, sulfasalazine and ALLN ± strongly reduced nuclear NF-kB binding activity in HeLa cells. Under these conditions, TNFa inducible expression of p22 PRG1/IEX-1 was abolished. RT ± PCR detected no TNFa-dependent elevation of p22 PRG1/IEX-1 mRNA levels (Figure 2b ) upon the addition of the NFkB inhibitors, whereas the PCR product of b-actin was still detectable in an unaltered fashion ( Figure 2b) . Similarly, Western blotting detected no TNFa-induced increase of p22 PRG1/IEX-1 immunoreactivity in HeLa cells preincubated with the NF-kB inhibitors (Figure 2c ).
NF-kB inhibition and apoptosis in HeLa cells
Inhibition of NF-kB activation renders HeLa cells being much more susceptible to Fas-and TNFadependent apoptosis. As demonstrated by annexinV labeling, the number of apoptotic HeLa cells (basal: 5 ± 8% of total) was rather low upon administration of TNFa (11 ± 15%) or the activating anti-Fas antibody PRG1/IEX-1 expression by NF-kB inhibitors. Serum starved (16 h) HeLa cells were treated with 0.3 nM TNFa in the presence or absence of 0.5 mM gliotoxin, 10 mM MG-132, 5 mM ALLN and 0.5 mM sulfasalazine or the vehicle (DMSO). After 30 min, nuclear protein was isolated for EMSA, after 1 h, total RNA was isolated for RT ± PCR and after 6 h total protein was isolated for Western blotting. (a) EMSA was conducted with a speci®c 32 P-labeled probe containing the NF-kB binding site of the p22 PRG1/IEX-1 promoter. Speci®city control (left panel) was done by competition with a 50-fold excess of cold oligos and by supershift for p50 and p65. (b) RT ± PCR was conducted with speci®c primers for p22 PRG1/IEX-1 and for b-actin. (c) Total protein lysates were submitted to SDS ± PAGE and subsequent Western blotting. Representative results from three independent experiments are shown CH-11 (20 ± 25%), whereas preincubation with gliotoxin, sulfasalazine, ALLN or MG-132 caused an increase of the apoptotic cell number up to 40 ± 55% in response to TNFa and up to 50 ± 70% in response to CH-11 (Figure 3 ). Similar to death receptor mediated apoptosis, preincubation with the NF-kB inhibitors led to an increase of the apoptotic cell number from 20 ± 25 to 60% if the DNA-damage inducing anti-cancer drug etoposide was administered for 24 h.
Effect of ectopically expressed p22
PRG1/IEX-1 on apoptosis of TRex-HeLa cells
As TNFa induced expression of p22 PRG1/IEX-1 seems to be indispensable from NF-kB activation and as the NF-kB activity is closely related to the regulation of apoptosis, we further investigated whether p22 AnnexinV labeling revealed that in the absence of tetracycline, serum starved (16 h) transfectants (either lacZ or p22 PRG1/IEX-1 ) exhibited a moderate apoptotic response if treated with TNFa or the CH-11 antibody for 24 h. As shown in Figure 4b , apoptosis occurred only in a limited number of lacZ-or p22 PRG1/IEX-1 -transfected TRex-HeLa cells: 15 ± 20% of TNFa and 25 ± 30% of CH-11 treated cells became apoptotic compared to a basal rate of apoptosis of 5 ± 10%. This apoptotic response was not dierent from that seen in untransfected cells treated without tetracycline. In contrast, if tetracycline was added 8 h prior to the addition of the apoptotic stimuli, the apoptotic response in p22 PRG1/IEX-1 transfected cells was signi®-cantly increased: 24 ± 28% of TNFa and 42 ± 47% of CH-11 treated cells underwent apoptosis (Figure 4b ), and the basal rate of apoptosis was also elevated up to 20%. Under the same conditions, tetracycline did not alter the apoptotic response of lacZ-transfected TRexHeLa cells (Figure 4b ), as well as of untransfected cells (not shown). The eect of p22 PRG1/IEX-1 expression on apoptosis was further studied in TRex-HeLa cells PRG1/IEX-1 or for b-galactosidase (lacZ) using the Eectene reagent. Upon transfection, cells were serumstarved for 12 h and used for further treatment as speci®ed below. (a) LacZ-or p22 PRG1/IEX-1 transfected TRex-HeLa cells were incubated with or without 1 mM tetracycline for 8 h. Then, total protein was isolated and submitted to Western blotting. A representative result from four independent experiments is shown. (b) LacZ-or p22 PRG1/IEX-1 transfected TRex-HeLa cells were incubated with or without 1 mM tetracycline for 8 h. Then, 0.3 nM TNFa, 100 ng/ml CH-11 or 10 mM etoposide were added. After 24 h, cells were harvested, stained with FITC-AnnexinV/PI and submitted to FACS analysis. Data express the fraction (%) of apoptotic cells from the total cell count (mean+s.d., n=4). *P50.02; **P50.01 (Students paired t-test) subject to DNA-damage by treatment with etoposide ( Figure 4b ). In the absence of tetracycline, 25% of either lacZ-or p22 PRG1/IEX-1 -transfected cells were driven into apoptosis upon administration of etoposide for 30 h. In the presence of tetracycline, an increase of etoposide-induced apoptosis (45 ± 50% apoptotic cells) was noted in TRex-HeLa cells transfected with p22 PRG1/ IEX-1 , but no such alteration was observed in lacZ transfected TRex-HeLa cells (Figure 4b ) or untransfected cells (not shown).
PRG1/IEX-1 on the cell cycle in TRex-HeLa cells
Since other studies implied a contribution of p22 PRG1/IEX-1 to the cell cycle regulation (Kobayashi et al., 1998; Segev et al., 2000) that might also in¯uence the apoptotic responsiveness of HeLa cells, PI-cell cycle analysis was conducted on TRex-HeLa cells transfected with tetracycline-inducible p22 PRG1/IEX-1 ( Figure 5 ). Under serum free conditions (12 h) and upon administration of tetracycline for 8 h, transfectants were further serum-starved for 16 h. Cell cycle analysis revealed that compared to lacZ transfected cells, TRexHeLa cells expressing p22 PRG1/IEX-1 were driven into the G2/M phase more rapidly: in the presence of tetracycline, 30+4% of p22 PRG1/IEX-1 transfectants (compared to 19+5% in the absence of tetracycline) fell into the G2/M fraction, whereas the number of cells in the G1-phase (48+3% compared to 56+6%) and in the S phase (19+3% compared to 27+4%) signi®cantly decreased. This tetracycline-dependent alteration in cell cycle distribution was not observed in lacZ-transfected ( Figure 5 ) or in untransfected TRex-HeLa cells (not shown). The eect of tetracycline induced p22 PRG1/IEX-1 expression on cell cycle progression was similarly seen in TRex-HeLa cells treated for 16 h with the mitotic poison vinblastine, hereby trapping all those cells in a G2/M arrest that moved through the cell cycle (Kaltschmidt et al., 1999) . As shown in Figure 5 , tetracycline addition caused an increase from 52+8% to 67+3% of p22 PRG1/IEX-1 transfected cells kept in the G2/M phase, whereas no change occurred in lacZ transfected or untransfected cells (not shown).
Cleavage of p22
PRG1/IEX-1 with hammerhead ribozymes affects cell cycle progression as well as apoptotic sensitivity in HeLa cells
To abolish the action of endogenous p22 PRG1/IEX-1 in HeLa cells, a highly speci®c antisense concatameric hammerhead ribozyme was generated and ligated into a constitutive expression vector (pCMV-2-8-9AS). Upon serum starvation (16 h) and subsequent stimulation with 1.5% FCS for 6 h, HeLa cells exhibited a strongly reduced protein level of endogenous p22 were driven into G2/M arrest to a lesser extent (30 ± 35%). In addition to its eect on the cell cycle, the presence of pCMV-2-8-9AS reduces the moderate cytotoxic eect of TNFa or CH-11. As shown in Figure 6c , the increase of apoptotic HeLa cells (basal=11%) in response to TNFa amounted up to 24%, if these cells were transfected with pCMV-2-8-9S or an empty vector (V). In contrast, pCMV-2-8-9AS transfectants did not exhibit this moderate but signi®cant gain in apoptotic cell number upon TNFa treatment. If induced by CH-11, the increase of apoptosis in vectoror pCMV-2-8-9S transfectants amounted up to 35%, whereas pCMV-2-8-9AS transferred cells became signi®cantly less apoptotic (20 ± 25%).
Discussion
In the present study, we investigated whether p22 PRG1/ IEX-1 is indeed a functional NF-kB target gene contributing to cell cycle control and the regulation of apoptosis. In HeLa cells, TNFa induced p22 PRG1/IEX-1 expression is in dispensable from NF-kB recruitment into the nucleus, as various inhibitors of NF-kB activation completely blocked p22 PRG1/IEX-1 expression upon TNFa treatment. This was shown for the IKK inhibitor sulfasalazine (Wahl et al., 1998) , the proteasome inhibitors MG132 or ALLN (Hellerbrand et al., 1998) , and for gliotoxin (Pahl et al., 1996; Kroll et al., 1999) . The lack of NF-kB activation rendered HeLa cells being more sensitive to apoptosis in response to TNFa. Similarly, the rather weak apoptotic response to Fas activation or to DNA damage induced by the anticancer drug etoposide was increased if NF-kB activation was abolished. This apoptotic sensitization is generally believed to be due to the suppression of NF-kB induced expression of apoptosis inhibitors like c-IAP (You et al., 1997; Stehlik et al., 1998) , Bcl-x L , (Chen et al., 1999; Lee et al., 1999) , A1/B¯1 (Zong et al., 1999; Wang et al., 1999b) and other yet unde®ned anti-apoptotic genes. . This sensitizing eect of p22 PRG1/IEX-1 to apoptotic stimuli predominates in the absence of serum, whereas in the presence of serum this eect of ectopically expressed p22 PRG1/IEX-1 was much less pronounced (results not shown), indicating that serum factors probably interfere with or prevail the actions of p22 PRG1/IEX-1 . These actions may be part of the cell cycle regulation, as shown by the accelerating eect of ectopically expressed p22 PRG1/IEX-1 on cell cycle progression in HeLa cells. The gain of cells in the G2/M phase due to p22 PRG1/IEX-1 expression occurred in the absence or presence of vinblastine and was more pronounced in serum starved cells. The eect of p22 PRG1/IEX-1 on the cell cycle and on apoptosis was further veri®ed by the fact that speci®c blockade of endogenous p22 PRG1/IEX-1 expression by a concatameric antisense hammerhead ribozyme reduced the speed of cell cycle progression in HeLa cells, whereas a sense ribozyme did not alter the cell cycle compared to vector or untransfected HeLa cells. The presence of the speci®c ribozyme also reduced the cytotoxic eects of TNFa and of the activating Fas antibody.
Our ®ndings led us to conclude that p22 PRG1/IEX-1 , albeit being a target gene of NF-kB, is not responsible for NF-kB mediated resistance to apoptosis. Instead, p22 PRG1/IEX-1 seems to contribute to alternate actions of NF-kB in the context of growth control and the regulation of cellular viability (Kaltschmidt et al., 2000) . This is supported by the recent observation that p22 PRG1/IEX-1 suppresses growth of breast cancer cells in an NF-kB dependent fashion (Segev et al., 2000) , but does not inhibit cell death. The authors suggest that under these conditions p22 PRG1/IEX-1 interferes with the cell cycle, but an increase of apoptosis may also play a role. As we could show that p22 PRG1/IEX-1 accelerates the transition into the G2-phase, it seems likely that p22 PRG1/IEX-1 might be involved into both, cell cycle regulation and apoptosis. On the one hand, this eect on the cell cycle may account for the growth inducing eect of p22 PRG1/IEX-1 reported recently (Kobayashi et al., 1998) , but, on the other, under certain conditions apoptosis may occur.
In this regard, the actions of p22 PRG1/IEX-1 are probably modulated by additional factors and cell-type speci®c conditions that may be related to NF-kBmediated actions on the cell cycle, i.e. the induction of cyclin D1 (Guttridge et al., 1999; Hinz et al., 1999) or the interference with p16/INK4 and p27 (Wol and Naumann, 1999) , both molecular events which accelerate cell cycle progression. Under certain conditions, NF-kB is also required for apoptosis via its inducing eect on Fas or TRAIL-receptor expression (Chan et al., 1999; Gibson et al., 2000) , its synergism with p53 (Ryan et al., 2000) and via other mechanisms (Lin et al., 1999; Kaltschmidt et al., 2000) . By inducing p22 PRG1/IEX-1 expression, i.e. via TNFa signaling, NFkB might sensitize certain cell types to the balance between mediators of apoptosis and their antiapoptotic counterparts. This mode of sensitization may be similar to the accelerated cell cycle progression that renders cells bearing c-myc or ras-ampli®cations to be prone to apoptotic triggers (Sakamuro et al., 1995; Jiang et al., 1996; Evan and Littlewood, 1998) raised by unfavourable growth conditions, DNA damage or death receptor activation. Furthermore, it has been recently reported that under certain conditions Cyclin G sensitizes cells to apoptosis (Okamoto and Prives, 1999) , thus supporting the generally accepted concept that cell death is facilitated by cell cycle progression. In this way, p22 PRG1/IEX-1 would be part of a signal initiated by NF-kB that per-se does neither induce nor inhibit cell death but that strongly augments an apoptotic response if other apoptotic signals prevail.
Materials and methods

Cell culture
HeLa cells were kept in culture (378C, 5% CO 2 , 85% humidity) in RPMI 40 (suppl. with 1% glutamine, 10% fetal calf serum) and TRex-HeLa cells (Invitrogen) were cultured in EMEM (suppl. with 1% glutamine, 10% fetal calf serum and 0.2 mM blasticidine).
Chemicals
ALLN and Mg-132 were from Biomol (Hamburg, Germany); Sulfasalazine, Gliotoxin, TNFa and PI were from Sigma (Deisenhofen, Germany). FITC-labeled Annexin-V was purchased from Clontech (Heidelberg, Germany) and restriction enzymes were provided by Pharmacia-Biotech (Freiburg, Germany). CH-11 antibody was from Coulter Immunotech (Hamburg, Germany)
RT ± PCR and Western blotting
Total RNA was isolated with the Qiashredder/RNeasy kit (Qiagen). RT ± PCR for the detection of p22 PRG1/IEX-1 was conducted as described recently (SchaÈ fer et al., 1999) . PCR products were veri®ed by DNA sequencing (LICOR 4000-L; MWG-Biotech). As internal mRNA control, b-actin was analysed with RT ± PCR amplimer primers (Clontech). PCR products were analysed by PAGE and subsequent EtBr staining. p22 PRG1/IEX-1 Western blotting was performed as described recently (SchaÈ fer et al., 1999) . For control, a monoclonal antibody against a-tubulin (SIGMA) was used.
Electrophoretic mobility shift assay
Nuclear extracts from TNFa-stimulated HeLa cells were submitted to electrophoretic mobility shift assay as described (SchaÈ fer et al., 1998b).
Measurement of apoptosis
As an early sign for apoptosis, the presence of phosphatidylserine in the plasma membrane outer lea¯et was measured by binding of FITC-labeled annexin-V (Clontech). Brie¯y, 10 5 cells were pelleted, re-suspended in 200 ml of HEPESbuered saline, and 10 ml of FITC-labeled enhanced-annexin V and 100 ng of propidium iodide (PI) were added. Upon incubation for 15 min at room temperature in the dark, samples were brought to 0.5 ml with PBS. Analysis was done by¯uorescence¯ow cytometry (Galaxy Argon Plus, Dako), and the results were analysed with the FLOMAX software (Dako). Those cells exhibiting high staining with AnnexinV were regarded as being apoptotic.
Cell cycle analysis
Cells were prepared for cell cycle analysis with propidium iodide (PI) as described recently (SchaÈ fer et al., 1999) . Samples were analysed by¯uorescence¯ow cytometry and cell cycle analysis was carried out using the FLOMAX software (Dako).
Construction and transfection of a tetracycline inducible p22 PRG1/IEX-1 expression vector
The full-length coding region of p22 PRG1/IEX-1 was cloned into a tetracycline inducible expression vector (pcDNA4TO; Invitrogen). This construct was checked by DNA sequencing (LICOR 4000-L; MWG-Biotech). For transient transfection, TRex-HeLa cells were plated onto six-well dishes until 40 ± 50% con¯uency. After 2 h serum starvation, cells were submitted to lipofection (8 ml/well Eectene, Qiagen) using 0.5 mg plasmid (pcDNA4/TO-LacZ as control, pcDNA4/TOp22 PRG1/IEX-1 ). After a 6 h period at 378C, two volumes of medium plus 1.5% FCS were added and incubation continued for 6 ± 10 h at 378C. Then, medium was replaced by EMEM+FCS+stimulants. Transfection ecacy was checked by analysing lacZ expression using a commercial Gal ELISA (Boehringer) as well as an in situ staining protocol.
Generation and transfection of vector-based hammerhead ribozymes
A vector based concatermic ribozyme-construct was generated consisting of three in vitro-tested hammered ribozymes. For each ribozyme the corresponding DNA templates were synthesized (Biometra), including terminal 5'-NheI-and 3'-XbaI-restriction sites. Upon annealing, ribozymal template DNA was ligated into a NheI/XbaI-restricted and dephosphorylated CMV-driven expression vector (pCDNA3.1, Invitrogen). These vectors were cut by XbaI and PmeI digestion and the intron of p22 PRG1/IEX-1¯a nked by a 5'-XbaIand a 3'-PmeI-site, was ligated directly adjacent to the ribozyme-insert. By consecutive digestion with XbaI/PmeI and NheI/PmeI, respectively, and subsequent ligation, a concatamer of three ribozymes separated by the intron sequence of p22 PRG1/IEX-1 was generated. In this way an antisense concatamer targeted to positions 112 ± 114, 274 ± 277 and 294 ± 297 of the p22 PRG1/IEX-1 mRNA (Gen Bank Acc. No S81914), as well as a sense control concatamer were produced. These constructs (0.4 mg per well) were transfected into HeLa cells plated onto six-well dishes by means of lipofection (Eectene, Qiagen).
Abbreviations NF-kB, nuclear factor-kB; TNFa, tumor necrosis factor a; IEX-1, X-ray inducible immediate early gene 1; PI, propidium iodide; FCS, fetal calf serum; EMEM, Eagle's Minimal Essential Medium.
